Varian Medical Systems Inc. (VAR)

118.37
1.10 0.96
NYSE : Health Technology
Prev Close 117.24
Open 117.67
Day Low/High 117.17 / 119.24
52 Wk Low/High 95.23 / 130.29
Volume 533.47K
Avg Volume 654.30K
Exchange NYSE
Shares Outstanding 91.50M
Market Cap 10.86B
EPS 2.70
P/E Ratio 50.49
Div & Yield N.A. (N.A)

Latest News

Varian Announces Third Quarter Fiscal Year 2018 Earnings Release Date

Varian Announces Third Quarter Fiscal Year 2018 Earnings Release Date

PALO ALTO, Calif., June 11, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced that it will report results for the third quarter of fiscal year 2018 after market close on Wednesday, July 25, 2018.

Varian To Demonstrate Advanced Brachytherapy Solutions At ABS 2018

Varian To Demonstrate Advanced Brachytherapy Solutions At ABS 2018

PALO ALTO, Calif., June 5, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be demonstrating its comprehensive portfolio of advanced brachytherapy solutions, June 7-9 in San Francisco, CA at the American Brachytherapy Society Annual Meeting...

Varian Medical Systems Becomes #156 Most Shorted S&P 500 Component, Replacing Xylem

The most recent short interest data has been released for the 05/15/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Varian Acquires Taiwan Distributor

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ACU, COP, ETR, KALU, NEU, OCIP, PLXS, ROK, SDI, TLF, VAR Downgrades: CYOU, FSV, KRG, TRN, UBS, UFI Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Varian To Equip New Karolinska Solna Hospital In Sweden With TrueBeam Radiotherapy Systems And Software

Company awarded contract for 8 TrueBeams, software and service

Varian Eclipse Customers Take Top Overall Spots At World Championships Of Treatment Planning

Varian Eclipse Customers Take Top Overall Spots At World Championships Of Treatment Planning

Customers take top four overall spots as well as top three spots in VMAT category

Varian And University Of Maryland School Of Medicine Reach Milestone In Training Medical Professionals At Maryland Proton Treatment Center

Varian And University Of Maryland School Of Medicine Reach Milestone In Training Medical Professionals At Maryland Proton Treatment Center

Treatment Center Has Trained More Than 150 Professionals at Cutting-Edge Facility

Varian ARIA Oncology Information System Earns ONC Health IT Certification From Drummond Group LLC

Varian ARIA Oncology Information System Earns ONC Health IT Certification From Drummond Group LLC

ARIA for medical and radiation oncology receives certification

Varian Acquires Evinance Innovation, Inc.

Varian Acquires Evinance Innovation, Inc.

Expands 360 Oncology care management platform with clinical decision support

Pinecrest Completes Strategic Sale Of Mobius To Varian

Pinecrest Completes Strategic Sale Of Mobius To Varian

Pinecrest Serves as Exclusive Financial Advisor to Mobius Medical Systems

TheStreet Quant Rating: B (Buy)